Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis

Craig C. Whiteford, Sven Bilke, Braden T. Greer, Qingrong Chen, Till A. Braunschweig, Nicola Cenacchi, Jun S. Wei, Malcolm A. Smith, Peter J Houghton, Christopher Morton, C. Patrick Reynolds, Richard Lock, Richard Gorlick, Chand Khanna, Carol J. Thiele, Mikiko Takikita, Daniel Catchpoole, Stephen M. Hewitt, Javed Khan

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Human tumor xenografts have been used extensively for rapid screening of the efficacy of anticancer drugs for the past 35 years. The selection of appropriate xenograft models for drug testing has been largely empirical and has not incorporated a similarity to the tumor type of origin at the molecular level. This study is the first comprehensive analysis of the transcriptome of a large set of pediatric xenografts, which are currently used for preclinical drug testing. Suitable models representing the tumor type of origin were identified. It was found that the characteristic expression patterns of the primary tumors were maintained in the corresponding xenografts for the majority of samples. Because a prerequisite for developing rationally designed drugs is that the target is expressed at the protein level, we developed tissue arrays from these xenografts and corroborated that high mRNA levels yielded high protein levels for two tested genes. The web database and availability of tissue arrays will allow for the rapid confirmation of the expression of potential targets at both the mRNA and the protein level for molecularly targeted agents. The database will facilitate the identification of tumor markers predictive of response to tested agents as well as the discovery of new molecular targets.

Original languageEnglish (US)
Pages (from-to)32-40
Number of pages9
JournalCancer Research
Volume67
Issue number1
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Tissue Array Analysis
Credentialing
Heterografts
Pediatrics
Gene Expression
Pharmaceutical Preparations
Neoplasms
Databases
Messenger RNA
Proteins
Gene Expression Profiling
Tumor Biomarkers
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Whiteford, C. C., Bilke, S., Greer, B. T., Chen, Q., Braunschweig, T. A., Cenacchi, N., ... Khan, J. (2007). Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Research, 67(1), 32-40. https://doi.org/10.1158/0008-5472.CAN-06-0610

Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. / Whiteford, Craig C.; Bilke, Sven; Greer, Braden T.; Chen, Qingrong; Braunschweig, Till A.; Cenacchi, Nicola; Wei, Jun S.; Smith, Malcolm A.; Houghton, Peter J; Morton, Christopher; Reynolds, C. Patrick; Lock, Richard; Gorlick, Richard; Khanna, Chand; Thiele, Carol J.; Takikita, Mikiko; Catchpoole, Daniel; Hewitt, Stephen M.; Khan, Javed.

In: Cancer Research, Vol. 67, No. 1, 01.01.2007, p. 32-40.

Research output: Contribution to journalArticle

Whiteford, CC, Bilke, S, Greer, BT, Chen, Q, Braunschweig, TA, Cenacchi, N, Wei, JS, Smith, MA, Houghton, PJ, Morton, C, Reynolds, CP, Lock, R, Gorlick, R, Khanna, C, Thiele, CJ, Takikita, M, Catchpoole, D, Hewitt, SM & Khan, J 2007, 'Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis', Cancer Research, vol. 67, no. 1, pp. 32-40. https://doi.org/10.1158/0008-5472.CAN-06-0610
Whiteford, Craig C. ; Bilke, Sven ; Greer, Braden T. ; Chen, Qingrong ; Braunschweig, Till A. ; Cenacchi, Nicola ; Wei, Jun S. ; Smith, Malcolm A. ; Houghton, Peter J ; Morton, Christopher ; Reynolds, C. Patrick ; Lock, Richard ; Gorlick, Richard ; Khanna, Chand ; Thiele, Carol J. ; Takikita, Mikiko ; Catchpoole, Daniel ; Hewitt, Stephen M. ; Khan, Javed. / Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. In: Cancer Research. 2007 ; Vol. 67, No. 1. pp. 32-40.
@article{2a9ea0ae535d4e738996d9d5737a1fab,
title = "Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis",
abstract = "Human tumor xenografts have been used extensively for rapid screening of the efficacy of anticancer drugs for the past 35 years. The selection of appropriate xenograft models for drug testing has been largely empirical and has not incorporated a similarity to the tumor type of origin at the molecular level. This study is the first comprehensive analysis of the transcriptome of a large set of pediatric xenografts, which are currently used for preclinical drug testing. Suitable models representing the tumor type of origin were identified. It was found that the characteristic expression patterns of the primary tumors were maintained in the corresponding xenografts for the majority of samples. Because a prerequisite for developing rationally designed drugs is that the target is expressed at the protein level, we developed tissue arrays from these xenografts and corroborated that high mRNA levels yielded high protein levels for two tested genes. The web database and availability of tissue arrays will allow for the rapid confirmation of the expression of potential targets at both the mRNA and the protein level for molecularly targeted agents. The database will facilitate the identification of tumor markers predictive of response to tested agents as well as the discovery of new molecular targets.",
author = "Whiteford, {Craig C.} and Sven Bilke and Greer, {Braden T.} and Qingrong Chen and Braunschweig, {Till A.} and Nicola Cenacchi and Wei, {Jun S.} and Smith, {Malcolm A.} and Houghton, {Peter J} and Christopher Morton and Reynolds, {C. Patrick} and Richard Lock and Richard Gorlick and Chand Khanna and Thiele, {Carol J.} and Mikiko Takikita and Daniel Catchpoole and Hewitt, {Stephen M.} and Javed Khan",
year = "2007",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-06-0610",
language = "English (US)",
volume = "67",
pages = "32--40",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis

AU - Whiteford, Craig C.

AU - Bilke, Sven

AU - Greer, Braden T.

AU - Chen, Qingrong

AU - Braunschweig, Till A.

AU - Cenacchi, Nicola

AU - Wei, Jun S.

AU - Smith, Malcolm A.

AU - Houghton, Peter J

AU - Morton, Christopher

AU - Reynolds, C. Patrick

AU - Lock, Richard

AU - Gorlick, Richard

AU - Khanna, Chand

AU - Thiele, Carol J.

AU - Takikita, Mikiko

AU - Catchpoole, Daniel

AU - Hewitt, Stephen M.

AU - Khan, Javed

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Human tumor xenografts have been used extensively for rapid screening of the efficacy of anticancer drugs for the past 35 years. The selection of appropriate xenograft models for drug testing has been largely empirical and has not incorporated a similarity to the tumor type of origin at the molecular level. This study is the first comprehensive analysis of the transcriptome of a large set of pediatric xenografts, which are currently used for preclinical drug testing. Suitable models representing the tumor type of origin were identified. It was found that the characteristic expression patterns of the primary tumors were maintained in the corresponding xenografts for the majority of samples. Because a prerequisite for developing rationally designed drugs is that the target is expressed at the protein level, we developed tissue arrays from these xenografts and corroborated that high mRNA levels yielded high protein levels for two tested genes. The web database and availability of tissue arrays will allow for the rapid confirmation of the expression of potential targets at both the mRNA and the protein level for molecularly targeted agents. The database will facilitate the identification of tumor markers predictive of response to tested agents as well as the discovery of new molecular targets.

AB - Human tumor xenografts have been used extensively for rapid screening of the efficacy of anticancer drugs for the past 35 years. The selection of appropriate xenograft models for drug testing has been largely empirical and has not incorporated a similarity to the tumor type of origin at the molecular level. This study is the first comprehensive analysis of the transcriptome of a large set of pediatric xenografts, which are currently used for preclinical drug testing. Suitable models representing the tumor type of origin were identified. It was found that the characteristic expression patterns of the primary tumors were maintained in the corresponding xenografts for the majority of samples. Because a prerequisite for developing rationally designed drugs is that the target is expressed at the protein level, we developed tissue arrays from these xenografts and corroborated that high mRNA levels yielded high protein levels for two tested genes. The web database and availability of tissue arrays will allow for the rapid confirmation of the expression of potential targets at both the mRNA and the protein level for molecularly targeted agents. The database will facilitate the identification of tumor markers predictive of response to tested agents as well as the discovery of new molecular targets.

UR - http://www.scopus.com/inward/record.url?scp=33846404136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846404136&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-0610

DO - 10.1158/0008-5472.CAN-06-0610

M3 - Article

VL - 67

SP - 32

EP - 40

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 1

ER -